Matheis Dennis 4
4 · DarioHealth Corp. · Filed May 8, 2023
Insider Transaction Report
Form 4
Matheis Dennis
Director
Transactions
- Purchase
Series B-2 Preferred Stock
2023-05-04$1000.00/sh+50$50,000→ 50 totalExercise: $3.37From: 2023-05-04Exp: 2026-05-04→ Common Stock
Holdings
- 82,620
Common Stock
Footnotes (2)
- [F1]The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
- [F2]The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date.